ReviewQuantitative imaging in medicine and surgery2014
Positron emission tomography/computerized tomography in lung cancer.
Review in Quantitative imaging in medicine and surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 35 citations in OpenAlex.
- Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data.Translational lung cancer research · 2024Article
- Review
- FAPI-74 PET/CT Using EitherJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021Article
- The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer.Annals of translational medicine · 2018Review
- Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging.Journal of the American Society for Mass Spectrometry · 2017Article
- Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.Chinese medical journal · 2016Article
- Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer.Oncotarget · 2016Article
- Prognostic significance of FoxM1 expression in non-small cell lung cancer.Journal of thoracic disease · 2016Article
- Present and future roles of FDG-PET/CT imaging in the management of lung cancer.Japanese journal of radiology · 2016Review
- [Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2016Article
- Evidence based imaging strategies for solitary pulmonary nodule.Journal of thoracic disease · 2014Article
- PET/CT imaging in lung cancer: indications and findings.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e TisilogiaReview
- Appropriateness criteria of FDG PET/CT in oncology.The Indian journal of radiology & imagingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Positron emission tomography (PET) using 2-(18F)-flouro-2-deoxy-D-glucose (FDG) has emerged as a useful tool in the clinical work-up of lung cancer. This review article provides an overview of applications of PET in diagnosis, staging, treatment response evaluation, radiotherapy planning, recurrence assessment and prognostication of lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.